STOCK TITAN
  1. Home
  2. News
  3. AGL

Agilon Health Inc - AGL STOCK NEWS

Welcome to our dedicated news page for Agilon Health (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on Agilon Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Agilon Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Agilon Health's position in the market.

News
agilon health Sets Date to Report First Quarter 2024 Financial Results
Rhea-AI Summary
Agilon Health, Inc. (AGL) will report its first quarter 2024 financial results on May 7, 2024, after the market closes. The company will host a conference call to discuss the results at 4:30 PM Eastern Time on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
News
agilon health Reports Fourth Quarter 2023 Results
Rhea-AI Summary
agilon health, inc. (AGL) reported a 72% revenue increase to $1.06 billion in Q4 2023, with Medicare Advantage membership up 68% to 388,400. However, the company faced challenges with a net loss of $230 million in Q4 2023 and a negative gross profit of $95 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
earnings
-
News
AGL Credit Management Has Three CLOs Named Finalists for DealCatalyst's 2024 Deals of the Year Awards
Rhea-AI Summary
AGL Credit Management LP's CLOs have been nominated for multiple prestigious awards at DealCatalyst's annual U.S. CLO Awards. AGL CLO 24 and AGL CLO 28 are finalists for Best Performing BSL CLO Deal of the Year, while AGL Core CLO 27 is a finalist for Innovative BSL CLO Deal of the Year. Founded by Peter Gleysteen, AGL has a strong track record in CLO investing, with over 30 CLOs priced in under five years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.02%
Tags
none
News
agilon health to Participate in the 44th Annual Cowen Health Care Conference
Rhea-AI Summary
agilon health, inc. (AGL) to participate in the 44th Annual Cowen Health Care Conference with a fireside chat on March 5. Investors can listen to the webcast on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.37%
Tags
conferences
-
News
agilon health Sets Date to Report Fourth Quarter and Full Year 2023 Financial Results
Rhea-AI Summary
agilon health, inc. (AGL) to release Q4 and full year 2023 financial results on February 27, 2023, followed by a conference call. Investors can access the call via phone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
News
agilon health Announces Chief Medical Officer Transition
Rhea-AI Summary
agilon health, inc. (AGL) announced that Dr. Benjamin Kornitzer will transition from his role as chief medical officer to a special advisor. Dr. Karthik Rao will serve as interim CMO until a successor is named. Dr. Rao and Dr. Kevin Spencer will co-lead the company's clinical strategy. Dr. Rao has a decade of experience in value-based care, while Dr. Spencer has over 25 years of experience in primary care practice and value-based care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.81%
Tags
none
News
agilon health Announces Tim Bensley to Retire as CFO
Rhea-AI Summary
agilon health, Inc. (NYSE: AGL) CFO Timothy Bensley to retire in 2024 after three years of service. The company has initiated the search for a new CFO. Bensley will serve in a consulting role during the transition. CEO Steve Sell expresses gratitude for Bensley's contributions and wishes him well in retirement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.56%
Tags
none
-
News
agilon health Provides 2023 Guidance Update, Initial 2024 View
Rhea-AI Summary
agilon health, inc. (NYSE: AGL) announces revised guidance expectations for 2023, reflecting higher-than-expected costs, and provides an initial outlook for 2024. The company is taking targeted actions to improve visibility, balance risk-sharing, and improve predictability of results in 2024 and over the long term. Revised 2023 medical margin expectation is $340 million to $360 million, approximately $110 million below the previous guidance range. Initial outlook for 2024 includes Medicare Advantage (MA) Members projected to be between 548,000 and 553,000, total revenues between $6,350 and $6,420, medical margin between $560 and $600, and adjusted EBITDA between $40 and $60.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.56%
Tags
none
-
News
agilon health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Agilon Health, Inc. (NYSE: AGL) to Participate in 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
conferences
News
Peer-Reviewed Study Finds Palliative Care Program Under agilon health’s Value-Based Model Significantly Improved Patient Outcomes
Rhea-AI Summary
agilon health, inc. (NYSE: AGL) announced the publication of new peer-reviewed data examining the impact of its full-risk, Total Care Model (agilon model) among both Medicare Advantage (MA) and ACO REACH patients enrolled in an innovative palliative care program. The study showed that patients enrolled in a primary care-led, integrated palliative care program delivered within a full-risk model spent an average of five more days at home during their final months and were almost two-thirds less likely to die in a hospital. The primary care-led, integrated palliative program also led to 39 percent fewer hospitalizations, a 48 percent reduction in intensive care unit days, and a 21 percent reduction in emergency department visits for patients enrolled in value-based palliative care. Total cost of care from the time of enrollment until death was 33 percent lower for patients in a community-based palliative care program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.12%
Tags
none
Stock AGL logo
Agilon Health Inc

NYSE:AGL

AGL Rankings

#1812 Ranked by Market Cap
#2614 Ranked by Stock Gains
N/A Ranked by Dividends

AGL Stock Data

1.83B
303.79M
1.37%
110.56%
11.48%
Dental Laboratories
Manufacturing
Link
United States
Austin

About AGL

a transformative partnership agilon health partners with primary care physicians to define a new standard of quality, efficiency and patient experience. we bring the people, solutions, capital and technology necessary to ensure their long-term success and to bring back the joy of practicing medicine. critical care we believe that every member of our team plays a critical role in transforming care for our patients. our customer service teams are the front line for physicians and patients navigating the system and, without our claims processing departments, our health plan partners and provider networks couldn’t do their jobs. no matter what your role is at agilon health, you can and will make a difference in the lives of the seniors and medicaid populations we serve. our culture and passion has already been embraced by nearly 500 employees in three states. and we are excited to welcome new members to the team as more physicians and patients experience the difference agilon health can ma